1.Research and application progress of organoids in liver cancer
Zehao LIU ; Chenxuan ZHANG ; Keshuai DONG ; Jia YU
Chinese Journal of Hepatobiliary Surgery 2023;29(12):945-949
Primary liver cancer is a major global public health issue and currently the second leading cause of cancer death worldwide. The continuous changes in early cancer detection and treatment strategies have improved the overall survival rate of patients. Emerging organoid technologies have had a dramatic impact on cancer research in recent years, and tumor organoids are widely used in basic and translational cancer research. Tumor organoid culture technology will bridge the gap among molecular genetics, biology and clinical treatment. In this review, we discussed the recent different applications of liver organoids in liver cancer biology and clinical translation, involving liver cancer molecular studies, microenvironment and metastasis studies and drug screening trials, in order to provide a reference for clinical practice.
2.Effect of the chicken zp1 gene on osteoblast mineralization.
Qiaoxian YUE ; Chenxuan HUANG ; Yinliang ZHANG ; Hui CHEN ; Rongyan ZHOU
Chinese Journal of Biotechnology 2023;39(7):2684-2694
The aim of this study was to clone the chicken zp1 gene encoding zona pellucida 1 (Zp1) and investigate its tissues expression profile and its effect on osteoblast mineralization. The expression level of zp1 was quantified in various tissues of laying hens and in the tibia of the pre- and post-sexual maturity by RT-qPCR. Zp1 overexpressed vector was transfected into chicken calvarial osteoblasts which were induced differentiation for 8 days, and the extracellular mineral and the expression of mineralization-related genes were detected. The full-length chicken zp1 gene is 3 045 bp, encoding 958 amino acids residuals, and has two N-glycosylation sites. The highest expression level of the zp1 gene was found in the liver, followed by the tibia and yolk membrane, while no expression was detected in the heart and eggshell gland. Compared with the pre-sexual maturity hens, the concentration of estrogen (E2) in plasma, the content of glycosaminoglycan (GAG) and the expression level of the zp1 gene in the tibia with post-sexual maturity were higher. The extracellular matrix and the level of osteoblast mineralization-related genes showed a significantly upregulated expression in chicken calvarial osteoblasts with Zp1 overexpressed and addition of estrogen. The expression of the zp1 gene is tissue-specific and positively regulated osteoblast mineralization under the action of estrogen, laying the foundation for elucidating the functional properties of Zp1 in chicken bones during the egg production period.
Female
;
Animals
;
Zona Pellucida Glycoproteins
;
Membrane Glycoproteins/metabolism*
;
Chickens/genetics*
;
Egg Proteins/metabolism*
;
Receptors, Cell Surface
;
Estrogens
3.Trends in the biological functions and medical applications of extracellular vesicles and analogues.
Yan ZHAO ; Xiaolu LI ; Wenbo ZHANG ; Lanlan YU ; Yang WANG ; Zhun DENG ; Mingwei LIU ; Shanshan MO ; Ruonan WANG ; Jinming ZHAO ; Shuli LIU ; Yun HAO ; Xiangdong WANG ; Tianjiao JI ; Luo ZHANG ; Chenxuan WANG
Acta Pharmaceutica Sinica B 2021;11(8):2114-2135
Natural extracellular vesicles (EVs) play important roles in many life processes such as in the intermolecular transfer of substances and genetic information exchanges. Investigating the origins and working mechanisms of natural EVs may provide an understanding of life activities, especially regarding the occurrence and development of diseases. Additionally, due to their vesicular structure, EVs (in small molecules, nucleic acids, proteins, etc.) could act as efficient drug-delivery carriers. Herein, we describe the sources and biological functions of various EVs, summarize the roles of EVs in disease diagnosis and treatment, and review the application of EVs as drug-delivery carriers. We also assess the challenges and perspectives of EVs in biomedical applications.
4.Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients.
Jiaxiang LIU ; Shuangtao ZHAO ; Chenxuan YANG ; Li MA ; Qixi WU ; Xiangzhi MENG ; Bo ZHENG ; Changyuan GUO ; Kexin FENG ; Qingyao SHANG ; Jiaqi LIU ; Jie WANG ; Jingbo ZHANG ; Guangyu SHAN ; Bing XU ; Yueping LIU ; Jianming YING ; Xin WANG ; Xiang WANG
Chinese Medical Journal 2023;136(2):184-193
BACKGROUND:
Breast cancer patients who are positive for hormone receptor typically exhibit a favorable prognosis. It is controversial whether chemotherapy is necessary for them after surgery. Our study aimed to establish a multigene model to predict the relapse of hormone receptor-positive early-stage Chinese breast cancer after surgery and direct individualized application of chemotherapy in breast cancer patients after surgery.
METHODS:
In this study, differentially expressed genes (DEGs) were identified between relapse and nonrelapse breast cancer groups based on RNA sequencing. Gene set enrichment analysis (GSEA) was performed to identify potential relapse-relevant pathways. CIBERSORT and Microenvironment Cell Populations-counter algorithms were used to analyze immune infiltration. The least absolute shrinkage and selection operator (LASSO) regression, log-rank tests, and multiple Cox regression were performed to identify prognostic signatures. A predictive model was developed and validated based on Kaplan-Meier analysis, receiver operating characteristic curve (ROC).
RESULTS:
A total of 234 out of 487 patients were enrolled in this study, and 1588 DEGs were identified between the relapse and nonrelapse groups. GSEA results showed that immune-related pathways were enriched in the nonrelapse group, whereas cell cycle- and metabolism-relevant pathways were enriched in the relapse group. A predictive model was developed using three genes ( CKMT1B , SMR3B , and OR11M1P ) generated from the LASSO regression. The model stratified breast cancer patients into high- and low-risk subgroups with significantly different prognostic statuses, and our model was independent of other clinical factors. Time-dependent ROC showed high predictive performance of the model.
CONCLUSIONS
A multigene model was established from RNA-sequencing data to direct risk classification and predict relapse of hormone receptor-positive breast cancer in Chinese patients. Utilization of the model could provide individualized evaluation of chemotherapy after surgery for breast cancer patients.
Humans
;
Female
;
Breast Neoplasms/genetics*
;
East Asian People
;
Neoplasm Recurrence, Local/genetics*
;
Breast
;
Algorithms
;
Chronic Disease
;
Prognosis
;
Tumor Microenvironment